These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4141910)

  • 1. The metabolic basis of the Refsum syndrome.
    Steinberg D
    Birth Defects Orig Artic Ser; 1971 Feb; 7(1):42-52. PubMed ID: 4141910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of the oxidative defect in phytanic acid degradation in patients with Refsum's disease.
    Mize CE; Herndon JH; Blass JP; Milne GW; Follansbee C; Laudat P; Steinberg D
    J Clin Invest; 1969 Jun; 48(6):1033-40. PubMed ID: 4181594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of phytanic acid omega-hydroxylation in human liver microsomes.
    Komen JC; Duran M; Wanders RJ
    Mol Genet Metab; 2005 Jul; 85(3):190-5. PubMed ID: 15979030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidation of the metabolic error in Refsum's disease: strategy and tactics.
    Steinberg D
    Adv Neurol; 1978; 21():113-24. PubMed ID: 83783
    [No Abstract]   [Full Text] [Related]  

  • 5. Refsum's disease: defective oxidation of phytanic acid in tissue cultures derived from homozygotes and heterozygotes.
    Herndon JH; Steinberg D; Uhlendorf BW
    N Engl J Med; 1969 Nov; 281(19):1034-8. PubMed ID: 4188238
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of pristanal dehydrogenase activity in peroxisomes: conclusive evidence that the complete phytanic acid alpha-oxidation pathway is localized in peroxisomes.
    Jansen GA; van den Brink DM; Ofman R; Draghici O; Dacremont G; Wanders RJ
    Biochem Biophys Res Commun; 2001 May; 283(3):674-9. PubMed ID: 11341778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP4 isoform specificity in the omega-hydroxylation of phytanic acid, a potential route to elimination of the causative agent of Refsum's disease.
    Xu F; Ng VY; Kroetz DL; de Montellano PR
    J Pharmacol Exp Ther; 2006 Aug; 318(2):835-9. PubMed ID: 16707724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Heredopathia atactica polyneuritiformis. Hexadecanoic acid storage disease (Refsum's disease). Definition, treatment and pathogenesis. A short review].
    Refsum S
    Psychiatr Neurol Med Psychol Beih; 1977; 22-23():11-8. PubMed ID: 95656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisomes, Refsum's disease and the alpha- and omega-oxidation of phytanic acid.
    Wanders RJ; Komen JC
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):865-9. PubMed ID: 17956234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phytanic acid oxidation: normal activation and transport yet defective alpha-hydroxylation of phytanic acid in peroxisomes from Refsum disease and rhizomelic chondrodysplasia punctata.
    Pahan K; Khan M; Singh I
    J Lipid Res; 1996 May; 37(5):1137-43. PubMed ID: 8725164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of fatty aldehyde dehydrogenase in the breakdown of phytol to phytanic acid.
    van den Brink DM; van Miert JN; Dacremont G; Rontani JF; Jansen GA; Wanders RJ
    Mol Genet Metab; 2004 May; 82(1):33-7. PubMed ID: 15110319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phytanic acid in patients with Refsum's syndrome and response to dietary treatment.
    Steinberg D; Mize CE; Herndon JH; Fales HM; Engel WK; Vroom FQ
    Arch Intern Med; 1970 Jan; 125(1):75-87. PubMed ID: 4188898
    [No Abstract]   [Full Text] [Related]  

  • 13. The nature of the metabolic defect in Refsum's disease.
    Steinberg D; Avigan J; Mize CE; Herndon JH; Fales HM; Milne GW
    Pathol Eur; 1968; 3(2):450-8. PubMed ID: 4176998
    [No Abstract]   [Full Text] [Related]  

  • 14. Refsum's disease: nature of the enzyme defect.
    Steinberg D; Herndon JH; Uhlendorf BW; Mize CE; Avigan J; Milne GW
    Science; 1967 Jun; 156(3783):1740-2. PubMed ID: 4180573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of the branched-chain fatty acids pristanic acid and Refsum disease-associated phytanic acid on mitochondrial functions and calcium regulation of hippocampal neurons, astrocytes, and oligodendrocytes.
    Rönicke S; Kruska N; Kahlert S; Reiser G
    Neurobiol Dis; 2009 Nov; 36(2):401-10. PubMed ID: 19703563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refsum disease: a defect in the alpha-oxidation of phytanic acid in peroxisomes.
    Singh I; Pahan K; Singh AK; Barbosa E
    J Lipid Res; 1993 Oct; 34(10):1755-64. PubMed ID: 7504046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of phytanic acid on the vitamin E status, lipid composition and physical properties of retinal cell membranes: implications for adult Refsum disease.
    Young SP; Johnson AW; Muller DP
    Clin Sci (Lond); 2001 Dec; 101(6):697-705. PubMed ID: 11724659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the biochemical defect in heredopathia atactica polyneuritiformis (Refsum's disease).
    Eldjarn L; Try K; Stokke O
    Pathol Eur; 1968; 3(2):459-67. PubMed ID: 4176999
    [No Abstract]   [Full Text] [Related]  

  • 19. Refsum disease, peroxisomes and phytanic acid oxidation: a review.
    Wanders RJ; Jansen GA; Skjeldal OH
    J Neuropathol Exp Neurol; 2001 Nov; 60(11):1021-31. PubMed ID: 11706932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of the enzymatic defect in phytanic acid storage disease (Refsum's disease).
    Hutton D; Steinberg D
    Neurology; 1973 Dec; 23(12):1333-4. PubMed ID: 4127989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.